ArticleInternational journal of women's health2024
Ruptured Ovarian Mature Cystic Teratoma with Adenocarcinoma Transformation: A Case Report.
Article in International journal of women's health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Ovarian mature cystic teratoma (MCT) is the most common ovarian tumor, and only a small fraction undergoes malignant transformation. The most prevalent malignant type of the ovary is squamous cell carcinoma, followed by adenocarcinoma. However, ruptured ovarian mature cystic teratoma with adenocarcinoma transformation is extremely rare. Case Presentation: A 75-year-old postmenopausal woman presented to the emergency room with abdominal pain following a CT examination, the patient was diagnosed with a ruptured ovarian MCT. Subsequently, surgery was performed. Finally, she was diagnosed with adenocarcinoma tumor originating from the MCT of the ovary based on histopathology and immunohistochemistry examination. Following six cycles of chemotherapy with carboplatin and paclitaxel, the patient underwent long-term follow-up, during which no recurrence was observed over 10 months of examinations. Conclusion: The cases of ruptured cystic teratomas are rare, and ruptured cancerous transformation in MCT is infrequently documented in the literature. Therefore, special attention should be paid when encountering such cases in medical practice, as they can easily be misdiagnosed as benign ovarian tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.